America is grappling with a severe mental health crisis, with alarming figures such as over 130 Americans dying by suicide each day, including more than 20 veterans. In response to treatment-resistant conditions like depression and PTSD, psychedelic-assisted therapies have surfaced as viable options. However, many Americans, including veterans, are traveling abroad to access these treatments due to insufficient federal support.
The Trump administration provided a boost for research in psychedelic therapies, and the FDA’s Breakthrough Therapy designation for drugs like psilocybin and MDMA marked progress. Yet, there is a pressing need for more federal involvement to ensure these therapies reach those in need within the U.S.
Two years ago, the bipartisan Congressional Psychedelics Advancing Therapies (PATH) Caucus sought feedback on integrating psychedelics into healthcare safely. Responses highlighted their transformative potential when administered in proper conditions. Therefore, establishing federal policies that enforce safe usage standards in medical settings is essential.
A national framework is required for secure and fair access to psychedelic treatments, centering on standard service delivery and practitioner credentialing. There’s consensus among stakeholders that guidance and verification systems should be in place prior to FDA approvals. Labeling requirements, best practices for “set and setting,” crisis response, and integration support before and after sessions are all crucial areas needing attention.
To harness the full public health benefits of psychedelic medicine, Congress and federal agencies must address these considerations directly. The integration of psychedelic therapies into American healthcare is imminent; the focus must be on safe and effective implementation. Establishing standards will not only protect patients but also ensure equitable access and provide significant health benefits for those suffering from serious mental and physical conditions.
Jack Bergman, representing Michigan’s 1st Congressional District, is a retired Marine Corps lieutenant general. Lou Correa represents California’s 46th Congressional District. They co-chair the Congressional PATH Caucus.
Axiom REACH Foundation Expands Cancer Support Efforts to Bangladesh 
Orthopedic Surgeon Advocates for Joint Health Through Basic Care 
Woman’s Vigilance Led to Early Breast Cancer Diagnosis 
Concerns over Kratom Derivatives Spur Federal Attention 
Study Links ADHD to Increased Dementia Risk 
The Role of Trained Advocates in Patient Care